세계의 세포 해리 시장 - 산업 규모, 점유율, 동향, 경쟁, 기회, 예측 : 유형별, 제품 유형별, 조직별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)

Cell Dissociation Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Type, By Product Type, By Tissue, By End User, By Region & Competition, 2020-2030F

US $ 4,500 ￦ 6,174,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,546,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 10,976,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 세포 해리 시장은 2024년에 7억 3,025만 달러로 평가되었고, 2030년에는 15억 4,784만 달러에 이를 것으로 예상되며, 예측 기간 중 CAGR은 13.34%를 나타낼 전망입니다.

이 성장은 주로 바이오 의약품 분야에서의 연구 노력의 확대, 맞춤형 의료에 대한 수요 증가, 세포 기반 연구에 대한 공적·정부 투자 증가에 의해 초래됩니다. 다양한 응용에서 매우 중요한 단계입니다. 조직 해리 기술의 진보, 줄기 세포에의 응용 연구 증가, 효소를 사용하지 않는 해리 방법에 대한 기호성이 향후 수년간 시장 확대를 더욱 뒷받침할 것으로 예측됩니다.

시장 개요
예측 기간	2026-2030년
시장 규모(2024년)	7억 3,025만 달러
시장 규모(2030년)	15억 4,784만 달러
CAGR(2025-2030년)	13.34%
급성장 부문	세포 분리
최대 시장	북미

시장 성장 촉진요인

세포 기반 치료 및 재생 의료에 대한 수요 증가

주요 시장 과제

해리 후 세포의 생존성과 기능적 완전성

주요 시장 동향

자동화 및 고처리량 세포 해리 기술

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 세포 해리 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율 및 예측
  • 유형별(조직 해리 및 세포 분리)
  • 제품 유형별(효소분해제품, 비효소분해제품, 기기 및 액세서리)
  • 조직별(상피조직, 결합조직, 기타)
  • 최종 사용자별(바이오테크놀러지 기업, 제약회사, 학술 및 연구기관 등)
  • 기업별(2024년)
  • 지역별
• 시장 맵

제6장 아시아태평양의 세포 해리 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국.
  • 인도.
  • 한국
  • 일본
  • 호주

제7장 유럽의 세포 해리 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 북미의 세포 해리 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제9장 남미의 세포 해리 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 세포 해리 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 합병과 인수
• 제품 개발

제13장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 협상력
• 고객의 협상력
• 대체품의 위협/서비스

제14장 세계의 세포 해리 시장 : SWOT 분석

제15장 경쟁 구도

• Becton, Dickinson and Company
• Miltenyi Biotec
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Sartorius AG
• Lonza Group Ltd.
• Danaher Corporation
• Merck KGaA
• STEMCELL Technologies
• QIAGEN NV

제16장 전략적 제안

제17장 기업 소개와 면책사항

KTH

영문 목차

영문목차

The Global Cell Dissociation Market was valued at USD 730.25 million in 2024 and is projected to reach USD 1,547.84 million by 2030, growing at a CAGR of 13.34% during the forecast period. This growth is primarily driven by expanding research efforts in the biopharmaceutical sector, increasing demand for personalized medicine, and rising public and government investments in cell-based research. Cell dissociation is a crucial step in various applications, including vaccine development and cell expansion processes. Advancements in tissue dissociation technologies, increased research in stem cell applications, and the preference for enzyme-free dissociation methods over enzymatic alternatives are expected to further support market expansion in the coming years.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 730.25 Million
Market Size 2030	USD 1,547.84 Million
CAGR 2025-2030	13.34%
Fastest Growing Segment	Cell Detachment
Largest Market	North America

Key Market Drivers

Rising Demand for Cell-Based Therapies and Regenerative Medicine

A major factor fueling the global cell dissociation market is the escalating demand for cell-based therapies and regenerative medicine. Cell dissociation is fundamental in isolating single cells from tissues, an essential step for downstream processes such as immunotherapy, stem cell research, and tissue engineering. Government-backed initiatives, like the U.S. Department of Health and Human Services' "Regenerative Medicine Innovation Project," which allocated over $10 million under the 21st Century Cures Act, are accelerating the adoption of these technologies. The increasing global prevalence of chronic conditions such as Parkinson's disease, cardiovascular disorders, and diabetes has also intensified the need for innovative, cell-based interventions. According to the WHO, chronic illnesses account for more than 70% of global deaths, prompting significant public and private investments in cellular therapies and, by extension, cell dissociation technologies.

Key Market Challenges

Cell Viability and Functional Integrity Post-Dissociation

Maintaining cell viability and functional integrity following dissociation remains a significant challenge in the global market. The enzymatic and mechanical processes used in dissociation can compromise cell membranes, alter surface markers, and disrupt intracellular functions, which are critical for applications like immunophenotyping, single-cell sequencing, and therapeutic use. This issue is particularly concerning in sensitive applications such as stem cell and T-cell therapies. Research funded by institutions like the NIH has shown that prolonged exposure to dissociation enzymes like trypsin can alter phenotypes and reduce the effectiveness of cell-based treatments. Additionally, the lack of standardized protocols for diverse tissue types adds variability to outcomes, impeding reproducibility and regulatory approval in translational research.

Key Market Trends

Automation and High-Throughput Cell Dissociation Technologies

A key trend shaping the cell dissociation market is the increasing adoption of automated and high-throughput technologies in laboratory workflows. Manual dissociation methods are time-intensive and susceptible to variability, particularly in high-volume or GMP-compliant settings. Automated systems streamline the dissociation process, reduce manual errors, and enhance yield and viability, making them increasingly attractive to both research institutions and commercial laboratories. These systems are essential for applications such as flow cytometry, CRISPR gene editing, and single-cell RNA sequencing. Government initiatives supporting the integration of artificial intelligence and smart technologies in biomedical research-such as the NIH's "Bridge2AI" program-are further driving the adoption of automation, ensuring more consistent and reproducible results across cell biology studies.

Key Market Players

• Becton, Dickinson and Company
• Miltenyi Biotec
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Sartorius AG
• Lonza Group Ltd.
• Danaher Corporation
• Merck KGaA
• STEMCELL Technologies
• QIAGEN N.V.

Report Scope:

In this report, the Global Cell Dissociation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Dissociation Market, By Type:

• Tissue Dissociation
• Cell Detachment

Cell Dissociation Market, By Product Type:

• Enzymatic Dissociation Products
• Non-Enzymatic Dissociation Products
• Instruments & Accessories

Cell Dissociation Market, By Tissue:

• Epithelial Tissue
• Connective Tissue
• Others

Cell Dissociation Market, By End User:

• Biotechnology Companies
• Pharmaceutical Companies
• Academic and Research Institutes
• Others

Cell Dissociation Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cell Dissociation Market.

Available Customizations:

Global Cell Dissociation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Dissociation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Tissue Dissociation & Cell Detachment)
  • 5.2.2. By Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments & Accessories)
  • 5.2.3. By Tissue (Epithelial Tissue, Connective Tissue, and Others)
  • 5.2.4. By End user (Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes and others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. Asia-Pacific Cell Dissociation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product Type
  • 6.2.3. By Tissue
  • 6.2.4. By End user
  • 6.2.5. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Cell Dissociation Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Tissue
      • 6.3.1.2.4. By End user
  • 6.3.2. India Cell Dissociation Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Tissue
      • 6.3.2.2.4. By End user
  • 6.3.3. South Korea Cell Dissociation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Tissue
      • 6.3.3.2.4. By End user
  • 6.3.4. Japan Cell Dissociation Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Product Type
      • 6.3.4.2.3. By Tissue
      • 6.3.4.2.4. By End user
  • 6.3.5. Australia Cell Dissociation Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Product Type
      • 6.3.5.2.3. By Tissue
      • 6.3.5.2.4. By End user

7. Europe Cell Dissociation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product Type
  • 7.2.3. By Tissue
  • 7.2.4. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cell Dissociation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Tissue
      • 7.3.1.2.4. By End user
  • 7.3.2. Germany Cell Dissociation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Tissue
      • 7.3.2.2.4. By End user
  • 7.3.3. United Kingdom Cell Dissociation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Tissue
      • 7.3.3.2.4. By End user
  • 7.3.4. Italy Cell Dissociation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Tissue
      • 7.3.4.2.4. By End user
  • 7.3.5. Spain Cell Dissociation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Tissue
      • 7.3.5.2.4. By End user

8. North America Cell Dissociation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product Type
  • 8.2.3. By Tissue
  • 8.2.4. By End user
  • 8.2.5. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Cell Dissociation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Tissue
      • 8.3.1.2.4. By End user
  • 8.3.2. Mexico Cell Dissociation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Tissue
      • 8.3.2.2.4. By End user
  • 8.3.3. Canada Cell Dissociation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Tissue
      • 8.3.3.2.4. By End user

9. South America Cell Dissociation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product Type
  • 9.2.3. By Tissue
  • 9.2.4. By End user
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Dissociation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Tissue
      • 9.3.1.2.4. By End user
  • 9.3.2. Argentina Cell Dissociation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Tissue
      • 9.3.2.2.4. By End user
  • 9.3.3. Colombia Cell Dissociation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Tissue
      • 9.3.3.2.4. By End user

10. Middle East and Africa Cell Dissociation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product Type
  • 10.2.3. By Tissue
  • 10.2.4. By End user
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Dissociation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Tissue
      • 10.3.1.2.4. By End user
  • 10.3.2. Saudi Arabia Cell Dissociation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Tissue
      • 10.3.2.2.4. By End user
  • 10.3.3. UAE Cell Dissociation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Tissue
      • 10.3.3.2.4. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Cell Dissociation Market: SWOT Analysis

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Miltenyi Biotec
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. GE Healthcare
• 15.5. Sartorius AG
• 15.6. Lonza Group Ltd.
• 15.7. Danaher Corporation
• 15.8. Merck KGaA
• 15.9. STEMCELL Technologies
• 15.10. QIAGEN N.V.

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료